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ABSTRACT: Both host and pathogen competitively manipulate coordination environments during bacterial infections.
Human cells release the innate immune protein siderocalin
(Scn, also known as lipocalin-2/Lcn2, neutrophil gelatinaseassociated lipocalin/NGAL) that can inhibit bacterial growth
by sequestering iron in a ferric complex with enterobactin
(Ent), the ubiquitous Escherichia coli siderophore. Pathogenic
E. coli use the virulence-associated esterase IroE to linearize the
Ent cyclic trilactone to linear enterobactin (lin-Ent). We
characterized lin-Ent interactions with Scn by using native
mass spectrometry (MS) with hydrogen−deuterium exchange
(HDX) and Lys/Arg speciﬁc covalent footprinting. These
approaches support 1:1 binding of both Fe(III)-lin-Ent to Scn
and iron-free lin-Ent to Scn. Both ferric and nonferric lin-Ent
localize to all three pockets of the Scn calyx, consistent with Scn capture of lin-Ent both before and after Fe(III) chelation.
These ﬁndings raise the possibility that Scn neutralizes both siderophores and siderophore-bound iron during infections. This
integrated, MS-based approach circumvents the limitations that frustrate traditional structural approaches to examining Scn
interactions with enterobactin-based ligands.

D

uring infections, pathogenic bacteria must often overcome substantial thermodynamic barriers to obtain iron
from host reservoirs. This competition between host and
pathogen represents a robust tug-of-war over transition metal
iron ions, which are growth-limiting nutrients for most
bacteria. Many bacterial pathogens activate the biosynthesis
of siderophores,1−3 low molecular-weight iron chelators that
scavenge iron for bacterial use. In response to these bacteria,
host cells secrete siderocalin (also known as lipocalin-2/Lcn2,
neutrophil gelatinase-associated lipocalin/NGAL, or 24p3) to
hinder iron acquisition by the pathogen.4−6 Unlike the
canonical iron-binding proteins that chelate iron ions directly,
Scn speciﬁcally binds ferric ions chelated with various
catecholates that are either pathogen-derived siderophores1
or host-derived metabolites.4−7 The E. coli siderophore
enterobactin (Ent) (Figure 1a) is the prototypical Scn ligand
and was recently detected alongside Scn in the urine of
patients with E. coli urinary tract infections (UTIs).7
High quality X-ray crystal structure analyses of Scn reveal an
eight-stranded antiparallel β-barrel core, deﬁned as the calyx,
that binds with ferric-catecholate complexes through positively
charged side chains of three residues (R81, K125, and
K134).2,8−11 These three residues form a distinctive hybrid
electrostatic/cation-π interaction network with the delocalized
© 2019 American Chemical Society

Figure 1. Chemical structure of enterobactin (Ent) (a) and linear
enterobactin (lin-Ent) (b).

π electrons of nearby ligand catechol functional groups.
Additional interactions including van der Waals and hydrogen
bonding are contributed by residues lining the calyx.1
Recent studies have used several biophysical tools to deﬁne
structural interactions between Scn and potential liSpecial Issue: Chemical Microbiology
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gands.1,5,8,11,12 Whereas optical1 and ﬂuorescence1,5 spectroscopies can provide useful binding data, they provide only
general structure information and report principally on
transition metal complex binding that provides distinctive
optical and ﬂuorescence quenching signals. Although X-ray
crystallography has provided detailed Scn structural data, the
chemical instability of enterobactin during cocrystallization has
been an irksome barrier to describing these complexes.4,8 The
value of NMR is complicated for ferric ligands, where the
presence of high-spin Fe(III) in the calyx would prevent useful
spectroscopic analysis of Scn interactions.12 To circumvent
these problems, we turned to fast, sensitive, mass spectrometry
(MS)-based structural proteomics approaches that complement the available, high quality X-ray crystallographic
structures. These MS techniques have been widely applied to
protein−protein interactions,13−16 protein folding/unfolding,17,18 protein structure characterization,19,20 protein conformational dynamics,21−23 binding aﬃnity,24 and binding
stoichiometry determination.25
Here, we describe the application of MS-based structural
proteomics to interrogate the interactions between Ent and
Scn in intact, bound ferric and aferric complexes. We focused
on Scn interactions with linear Ent (2,3-DHB-LSer)3 (lin-Ent)
(Figure 1b), a major secreted form of enterobactin produced
by extraintestinal pathogenic E. coli in culture26 and during
human infections.7 Enterobacteria carrying the virulenceassociated iroA locus encode IroE, an esterase that catalyzes
monohydrolysis of the Ent trilactone to yield lin-Ent.7,27,28
Although ﬂuorescence data support the binding of both ferricEnt and ferric-lin-Ent to Scn,7,8 there is no structure for these
complexes.
To characterize lin-Ent interactions with Scn, we combined
native MS, hydrogen−deuterium exchange mass spectrometry
(HDX-MS), and speciﬁc covalent footprinting. Native MS has
few restrictions on mass range29,30 and establishes ligand
binding and its stoichiometry. We observed the expected 1:1
binding between lin-Ent and Scn. HDX-MS31−33 provides
localized (peptide-level) structural information on Scn upon
ligand binding. We determined the regions of Scn that gain
protection upon ligand binding. Speciﬁc covalent footprinting
adds residue speciﬁcity to the HDX data and identiﬁes the
binding site.34−36 We used Lys and Arg-speciﬁc footprinting to
follow conformational changes of the protein on the residuelevel. The results indicate that ferric and aferric lin-Ent share a
binding interface, with ferric lin-Ent-bound Scn showing higher
stability. These observations support the intriguing possibility
that Scn may capture Ent prior to iron-binding during
infections.
The progressive design of our studies from “sketch” to
“detail” provides holistic structural information on solutionstate Scn and Scn complexes with both ferric and aferric
ligands. The binding site we detected for ferric and aferric linEnt to Scn is consistent with crystallographic data, adding
conﬁdence to our methods. Moreover, we detected ligandinduced Scn conformational changes not seen in the X-ray
crystal complex structure. This integrated platform also
provides useful structural information from stoichiometry to
conformational change and residue speciﬁc binding, and the
approach can be applied to compare directly both ferric and
aferric complexes. It will facilitate studies of Scn in complex
with both bacterial and human derived ligands as we work
toward therapeutic intervention.

Articles

RESULTS AND DISCUSSION
Native MS. We used nondenaturing, native MS to (1)
verify the molecular weight of Scn, (2) test whether both ferric
and aferric lin-Ent bind to Scn, and (3) determine the binding
stoichiometry of the complex.
Scn appeared at m/z 2068.3, 2298.0, and 2585.2 as [Scn
+10H+]10+, [Scn +9H+]9+, and [Scn +8H+]8+ charge states,
giving a MW of 20674.7 ± 3.2 Da (Figure 2). The peaks to the

Figure 2. Native mass spectra of Scn (green square), the lin-Entbound Scn complex (yellow triangle), and the ferric lin-Ent-bound
Scn complex (pink circle). (The concentrations of Scn, lin-Ent, and
FeCl3 are 40 μM, 60 μM, and 72 μM, respectively.)

right of the main peaks indicate an impurity of Scn, likely Scn
bearing a 115 Da modiﬁcation. Following equilibration with
Fe(III)-lin-Ent, we found a new peak shifted by 737.8 Da,
corresponding to ferric lin-Ent bound to Scn in a 1:1 ratio.
Although the m/z shifts to higher values, the charge state
distribution does not change. Given that native protein charge
states are mainly dependent on the folded protein’s exposed
surface area,37,38 the unchanged Scn charge state of the lin-Entbound complex is attributable to a stable, high-order protein
structure that changes little with binding. Its surface positive
charge is unchanged where the −3 charge of the ferric lin-Ent
ligand is neutralized by the three protonated amino acid side
chains shielded within the calyx.
With lin-Ent binding, we saw an additional species shifted by
687.9 Da, allowing the conclusion that Scn can bind lin-Ent
both in its iron-laden and iron-free state. Binding of aferric Ent
to Scn was previously reported by cocrystallization during
which the Ent was hydrolyzed.5 Fluorescence studies of Scn
ligand binding rely on tryptophan quenching, which is likely
due to a heavy-metal eﬀect and therefore insensitive to aferric
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Figure 3. Structure: Average percentage diﬀerences in deuterium uptake between apo-Scn and aferric lin-Ent-bound Scn as per color coding on an
X-ray crystal structure of TrenCam-bound Scn (PDB 3HWG). Insets: HDX kinetic data for selected peptides in the bound and unbound state
(Apo-Scn (black) and aferric lin-Ent-bound Scn (red)).

complexes. To our knowledge, this is the ﬁrst convincing
solution phase data of the aferric lin-Ent-Scn complex with
intact lin-Ent. This result is further motivation to pursue MSbased studies of Scn complexes.
Peptide-Level HDX Analysis of Unbound-Scn. Because
native spray MS provides limited structural detail on the
protein−ligand interaction, we turned to HDX to obtain sitespeciﬁc (peptide-level) information about likely binding sites.
As a reversible footprinting approach with minimal perturbation of the protein, HDX should detect conformational
changes of Scn at the peptide level. The normal quench for
HDX is 4 M urea or guanidine at pH 2.5 to minimize HDX
back exchange. Lack of signiﬁcant change in the secondary
structure of Scn from pH 7.4 to pH 2.01 indicates its high
stability and forecasts obstacles in its digestion. We tried the
traditional guanidine reagents, but this approach only achieved
∼87% coverage with 37 peptides in the digest (Figure S1).
Traditional urea reagent similarly gave poor coverage of the
protein (data not shown). In addition, there was a large
amount of undigested protein as shown by the chromatogram
(Figure S2). We assume that the 8-stranded antiparallel βbarrel fold makes Scn very resistant to denaturation under
normal quench buﬀer conditions (pH = 2.5). Therefore, we
sought an alternative way to denature Scn eﬃciently while
minimizing HDX back exchange. Using triﬂuoroethanol as
solvent to facilitate the denaturation of Scn, we obtained a
coverage map of ∼93% of the full-length protein sequence with
92 digested peptides (Figure S3) and a negligible amount of
undigested protein (Figure S4).
To obtain coarse-grained structural information, we
measured the HDX for unbound Scn and compared it with
that of aferric lin-Ent-bound and ferric lin-Ent-bound Scn at 37
°C within the same time range (10 s to 4 h) (Figures S5 and
S6). (Note that there are two additional residues at the
beginning of the expressed Scn sequence, so there is a tworesidue shift of the residue numbers compared with those
described previously (e.g., R81 shows up as R83, K125 shows
up as K127, and K134 shows up as K136).)
Most of the N-terminal region (residues 1−33) is ﬂexible or
solvent-exposed, as shown by a more than 50% deuterium
uptake within 10 s and an increasing extent of exchange to
∼70% at longer time. A four-turn α-helix (residues 147−162
within peptides 140−150 and 150−157) also shows solvent
exposure or ﬂexibility according to HDX. Peptide 158−176 in

the C-terminal region maintains some protection, exhibiting a
slow rate of HDX, which is attributed to the more ordered βstrand at the C terminus. With these exceptions, Scn is quite
rigid and structured, as only a few peptides show 90% exchange
within 15 min at 37 °C, in agreement with the X-ray crystal
structure.8
Diﬀerential HDX Analyses of the lin-Ent-bound Scn
and ferric lin-Ent-bound Scn Complexes. The highly
sculpted Scn calyx lined with three positively charged residues
(R81, K125, and K134) is thought to form hybrid electrostatic/cation-π interactions with catecholate ligands.1,4 To
probe the siderophore binding induced conformational
changes of Scn, we performed two sets of comprehensive
diﬀerential HDX experiments of full length Scn: (1) in the
presence and absence of aferric lin-Ent (Figures S5 and 3) and
(2) in the presence and absence of ferric lin-Ent (Figures S6
and S7).
The ﬁrst diﬀerential HDX analysis between apo-Scn and Scn
bound with aferric lin-Ent should locate the siderophore
binding site. To verify our conclusions that the diﬀerences in
HDX kinetics between bound and unbound are signiﬁcant, we
compared the sum of all the diﬀerences in the kinetic plots to
the propagation error (the square root of the sum of the
squares of all standard deviations). If the accumulated
diﬀerences are more than 3 times the propagation error, the
probability that HDX occurring at that region is signiﬁcantly
diﬀerent between bound and unbound is 99.7% (Figure S6a).
Four regions of Scn exhibit signiﬁcant deuterium uptake
diﬀerences, including regions represented by peptides 34−42,
60−72, 94−109, and 124−139.
As a reference, we used a crystal structure of Scn bound with
TrenCam, an Ent analog with a nonhydrolyzable, tertiary
amine backbone (PDB 3HWG).5
Previous NMR and X-ray crystallography studies found R81,
K125, and K134 (shown as R83, K127, and K136) to be
important in binding.8,10 The decreased HDX seen in the
proteolytic peptide 124−139 (containing K127 and K136)
upon lin-Ent binding is consistent with the expected cation-π
interactions (Figures 3 and S5). The peptide containing R83
does not show any noticeable deuterium uptake diﬀerence,
possibly because the peptide covering R83 is long, and the
deuterium uptake diﬀerence may be diluted by many invariant
residues in the 14-residue peptide (Figure S5). In addition,
binding sites are not always mapped by HDX.39 It is also
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possible that structural rigidity permits the ligand to interact
with the R83 side chain without conformationally aﬀecting the
adjoining peptide backbone.
Peptides 34−42 and 60−72 do not contain residues known
to bind the ligand directly but do exhibit protection upon linEnt binding. This suggests that conformational changes occur
in these regions (Figures 3 and S5). According to the 3D
structure, these two regions are part of the eight-stranded β
barrel. Binding to lin-Ent may “squeeze” the core of this β
barrel, inducing a tight, compact structure, thereby slowing
HDX of some β-strands of the core structure. These peptides
undergo slow HDX such that the diﬀerence in deuterium
uptake does not become signiﬁcant until 120 s. This
divergence is consistent with protection in these two regions
induced by ligand binding. Slow HDX and the delay before
divergence emerges are consistent with rigidity in this region of
the protein.
The region represented by peptide 94−109 contains part of
two β-strands of the eight-stranded β barrel and a ﬁve-residue
α-helix. This region shows ∼50% deuterium uptake within 10 s
and ∼80% in 4 h (Figures 3 and S5). Its kinetic curves are
divergent at the start of HDX, merge at later time points, and
show high rates of exchange throughout. That this α-helix is
more solvent exposed and likely more ﬂexible than the core of
the protein contributes to its fast HDX throughout. The βstrands are certainly more rigid, contributing to slower HDX
for those regions.
We made a second HDX diﬀerential comparison of apo-Scn
and ferric lin-Ent-bound Scn to understand the role of iron in
the binding process (Figures S6b, S7, and S8). Four regions
represented by peptic peptides 34−42, 60−72, 94−109, and
124−139 become protected by binding, nearly identical with
the binding of aferric lin-Ent, and another region (81−94) now
shows noticeable protection with ferric lin-Ent binding. Region
124−139, containing the two binding residues K127 and K136,
shows more signiﬁcant protection upon ferric lin-Ent binding
compared to that of aferric (Figures 3 and S7). Compared with
a small diﬀerence upon lin-Ent binding, the peptide 81−94
(containing binding residue R83) exhibits a greater diﬀerence
in HDX upon ferric lin-Ent binding (Figures S5, S6b, S7).
These ﬁndings suggest that the ferric ligand induces a more
compact protein structure than the aferric ligand, potentially
reﬂecting higher aﬃnity binding.
Lys and Arg Footprinting. To pinpoint the residues that
are involved in binding, we implemented speciﬁc and

irreversible covalent footprinting. This approach should give
higher spatial resolution than does HDX.
Because the binding residues are likely to be Lys and Arg, we
chose two water-soluble reagents, ethyl acetimidate hydrochloride (ETAT) and methyl glyoxal (MG) (eqs 1 and 2), to
modify Lys and Arg, respectively. Although these types of
reagents have been used for protein modiﬁcations since the
1960s, their application in MS-based protein footprinting was
more recent.13,40−43 These labeling reactions maintain the
positive charge in the protein, and the irreversible binding
permits a canonical bottom-up proteomics analysis. ETAT
reacts with the amine group of Lys by an SN2 reaction giving a
unique mass shift of +41.0265 Da (eq 1), whereas MG, a
vicinal dicarbonyl, reacts with Arg to form a cyclic adduct that
shifts the mass +72.0211 Da (eq 2). It is common for the MGlabeled product to lose one molecule of water.
We evaluated the reactivity of ETAT and MG at diﬀerent
time points (Figure S9). The mass spectral peaks representing
one ETAT and two ETAT modiﬁcations increase as the
labeling time increases (e.g., ETAT modiﬁcation extent of
unbound Scn increases from 31% to 67% as time increases
from 1 to 10 min) (Figure S9a and S9b). The diﬀerence
between unbound and bound is readily apparent, becoming
more so after 5 min (51% for Scn vs 30% for siderophorebound Scn) (Figure S9c). The modiﬁcation extent for MG
footprinting also systematically increases with time (Figure

Figure 4. Comparison of the modiﬁcation extents of peptides produced by digestion after (a) 5 min of ETAT footprinting and after (b) 5 min of
MG footprinting (Scn light gray, lin-Ent-bound Scn dark gray, and ferric lin-Ent-bound Scn blue or purple).
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residues to solvent (monitored by ETAT footprinting). This
eﬀect was also seen in other protein systems.44,45

S9d, 9e, 9f). We selected 5 min as the optimum labeling time
to record diﬀerences between the three states.
We next asked whether ETAT and MG footprinting can
identify lin-Ent and ferric lin-Ent binding sites of Scn with
good spatial resolution. To answer this question, we digested
the protein and analyzed the lysate by LC/MS/MS by using a
typical proteomics protocol. The sequence coverage of Scn is
∼98%, ensuring a nearly complete picture of the protein. We
integrated the extracted ion chromatogram (EIC) signal
intensities for each labeled peptide and its unlabeled
counterpart to give a modiﬁcation ratio (Figures S10, S11,
and S12). The labeled peptides are more hydrophobic, eluting
later than their unmodiﬁed counterparts. MS/MS data conﬁrm
that K136 and K127 can become ETAT modiﬁed, and R83 can
become MG modiﬁed. The most abundant charge states are
the same before and after the labeling, consistent with ETAT
and MG labeling maintaining a positive charge on Lys and Arg,
respectively.
We can assign with high conﬁdence that R83, K127, and
K136 interact with the ligand, causing a decrease in their
solvent accessible surface area upon binding (p value less than
0.01) (Figure 4). Indeed, these three positively charged
residues were reported to intercalate with the catechol rings of
the ligand and form a siderophore:Scn complex.1 The
consistency between our results and those previously published
conﬁrms our understanding of Ent-Scn binding while
validating the methods presented here as useful and accurate
in Scn studies.
There are some residues that show less certain conformational change, including R74, R132, and R142. The p values for
these are more than 0.01, decreasing conﬁdence in their
diﬀerences, but the modiﬁcation extent diﬀerence is >50%
(Figure 4b and Table S2). To check whether the decreased
modiﬁcation correlates with solvent accessible surface area
(SASA), we calculated the SASA between Scn and ferric linEnt bound Scn (Figure S13). Upon ligand binding, there is an
∼60% MG modiﬁcation decrease on R74, consistent with the
decreased SASA (50.7 Å2 for Scn vs 36.1 Å2 for lin-Ent bound
Scn). Although the HDX experiment did not provide
information on peptide 73−80, the nearby region represented
by peptide 58−72 exhibits pronounced protection following
ligand binding. Thus, R74 may reorient as part of the
conformational change in this region. R132 falls in the peptide
region 124−139 where there is a signiﬁcant deuterium uptake
diﬀerence, suggesting this residue is associated indirectly with
ligand binding. There is no signiﬁcant diﬀerence in the SASA
of R132 in bound and unbound states (Figure S13) so
decreased footprinting upon ligand binding is likely explained
by changes in chemical reactivity, steric hindrance of nearby
amino acids, and the protein microenvironment. R142
undergoes a substantial decrease in SASA upon ligand binding
(54 Å2 for Scn vs 8.0 Å2 for ferric lin-Ent-bound Scn). This is
likely the cause for the diﬀerence in MG modiﬁcation.
Residues K64, K100, and K126 show no diﬀerence in ETAT
footprinting, indicating that they are not critical binding
residues. Their corresponding peptides, 60−72 and 94−109,
show measurable HDX diﬀerences. This discrepancy between
ETAT footprinting and HDX results is consistent with remote
conformational changes in this region, rather than direct ligand
binding. This may occur when stabilization of Scn upon ligand
binding limits peptide backbone ﬂexibility and accessibility
(monitored by HDX) more than the exposure of lysine

■

CONCLUSIONS
Native MS, HDX, and chemical footprinting support a
common Scn binding interface for lin-Ent and ferric-lin-Ent.
The ferric lin-Ent interface is consistent with the model
developed by the laboratory of Roland Strong.5 It is notable
that the three pockets of the Arg and Lys-rich Scn calyx bind
both ferric and aferric lin-Ent, because the latter molecule lacks
the rigidity and anionic character of ferric Ent complexes. Ent
fully occupies the ﬁrst coordination sphere of Fe(III) with its
six deprotonated catechol rings, making the Ent structure more
rigid and sterically matched to the Scn calyx.2 Similar binding
of ferric and aferric lin-Ent to the same Scn site suggests that
Arg and Lys form similar cation-π interaction networks with
ferric and aferric catechols. Minor diﬀerences in chemical
footprinting may relate to diﬀerences in structure or stability
between ferric and aferric lin-Ent.
These new data raise the possibility that Scn may counteract
the bacterial enterobactin system not only by sequestering Entbound iron but also by sequestering aferric Ent. In this model,
Fe(III) access to Ent is limited by sequestration of its ligands
in the calyx, which is further shielded by the outward-facing
Ent serine polyester backbone. Similar interactions are likely
for cyclic Ent, which locks in the radial symmetry of catechols.
In this context, Ent linearization confers no clear beneﬁt to the
pathogen. It is possible that linearization facilitates pathogenesis in other contexts28 or that its virulence-association
reﬂects C-glycosylation of Ent catalyzed by the associated IroB.
A better understanding of chemical microenvironments during
infection may yield more deﬁnitive answers.
The analytical platform described here will be useful in
studies of other ligands and mutant proteins, particularly in
conjunction with crystallographic data. The ability to directly
compare the ligand binding site and detect ligand-induced
conformational changes of Scn for chemically labile ferric and
aferric siderophores that defy stable crystallization is
particularly useful. This ability arises because our approach
does not rely on transition metal-dependent ﬂuorescence
quenching and avoids paramagnetic ferric ion interferences
(e.g., as in NMR).
Finally, Lys and Arg speciﬁc footprinting, as a complement
to HDX, pinpoints residue-level information about the protein
structure and binding site. This can be used to ask detailed
questions about the binding of other ligands to Scn.26 The
overall approach can also be extended to other proteins with
stable and rigid structures or proteins rich with Lys and Arg
that are involved in interactions via salt bridges. The intrinsic
protease resistance of Scn led us to introduce improvements in
the digestion protocol for HDX by using triﬂuoroethanol to
facilitate the denaturation of stable and rigid Scn. We boosted
the coverage from ∼87% to ∼93% of the full-length protein
sequence and increased peptic peptides from 37 to 92.
Nonaqueous solvents may have broader advantages for other
extracellular innate immune proteins and will be explored in
future work.
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